Focal Laser Ablation of Prostate Cancer: Phase I Clinical Trial Academic Article uri icon

Overview

MeSH Major

  • Biopsy, Needle
  • Magnetic Resonance Imaging
  • Prostatic Neoplasms
  • Ultrasonography, Interventional

abstract

  • Focal laser ablation of the prostate is feasible and safe in men with intermediate risk prostate cancer without serious adverse events or changes in urinary or sexual function at 6 months. Comprehensive biopsy followup indicates that larger treatment margins than previously thought necessary may be required for complete tumor ablation.

publication date

  • January 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2015.12.083

PubMed ID

  • 26748164

Additional Document Info

start page

  • 68

end page

  • 75